Aspalatone Prevents VEGF‐Induced Lipid Peroxidation, Migration, Tube Formation, and Dysfunction of Human Aortic Endothelial Cells

Although aspalatone (acetylsalicylic acid maltol ester) is recognized as an antithrombotic agent with antioxidative and antiplatelet potential; its efficacy in preventing endothelial dysfunction is not known. In this study, we examined the antiangiogenic, antioxidative, and anti‐inflammatory effect of aspalatone in human aortic endothelial cells (HAECs). Specifically, the effect of aspalatone on VEGF‐induced HAECs growth, migration, tube formation, and levels of lipid peroxidation‐derived malondialdehyde (MDA) was examined. Our results indicate that the treatment of HAECs with aspalatone decreased VEGF‐induced cell migration, tube formation, and levels of MDA. Aspalatone also inhibited VEGF‐induced decrease in the expression of eNOS and increase in the expression of iNOS, ICAM‐1, and VCAM‐1. Aspalatone also prevented the VEGF‐induced adhesion of monocytes to endothelial cells. Furthermore, aspalatone also prevented VEGF‐induced release of inflammatory markers such as Angiopoietin‐2, Leptin, EGF, G‐CSF, HB‐EGF, and HGF in HAECs. Thus, our results suggest that aspalatone could be used to prevent endothelial dysfunction, an important process in the pathophysiology of cardiovascular diseases.